The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel …

C Nugent, G Yiu, S Song, C Caracta - Journal of Asthma, 2018 - Taylor & Francis
ABSTRACT Objective: Characterize fluticasone propionate (Fp) and combination fluticasone
propionate and salmeterol (FS) pharmacokinetic and safety profiles, delivered via a novel …
被引用次数：5 相关文章

The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel …

C Nugent, G Yiu, S Song, C Caracta - … of the Association for the Care …, 2017 - europepmc.org
Objective Characterize fluticasone propionate (Fp) and combination fluticasone propionate
and salmeterol (FS) pharmacokinetic and safety profiles, delivered via a novel, inhalation …

The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel …

C Nugent, G Yiu, S Song… - The Journal of asthma …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective Characterize fluticasone propionate (Fp) and combination fluticasone propionate
and salmeterol (FS) pharmacokinetic and safety profiles, delivered via a novel, inhalation …